171 related articles for article (PubMed ID: 13626994)
1. Search for a neuromuscular blocking agent in the blood of patients with myasthenia gravis.
NASTUK WL; STRAUSS AJ; OSSERMAN KE
Am J Med; 1959 Mar; 26(3):394-409. PubMed ID: 13626994
[No Abstract] [Full Text] [Related]
2. [Severity of myasthenia gravis is related to the degree of neuromuscular blocking effect by isoflurane].
Kadosaki M; Enzan K; Horiguchi T; Komatsu H; Suzuki M
Masui; 1993 Jun; 42(6):906-9. PubMed ID: 8320811
[TBL] [Abstract][Full Text] [Related]
3. Neuromuscular transmission in myasthenia gravis.
CHURCHILL-DAVIDSON HC; RICHARDSON AT
J Physiol; 1953 Nov; 122(2):252-63. PubMed ID: 13118536
[No Abstract] [Full Text] [Related]
4. Neuromuscular blockade with atracurium besylate in a patient with myasthenia gravis.
Murphy DF; Magner JB
Ir J Med Sci; 1986 Jun; 155(6):202-3. PubMed ID: 3755425
[No Abstract] [Full Text] [Related]
5. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
6. [Neuromuscular junction: pharmacology, toxicology and clinical use of neuromuscular blocking agents].
Conte-Camerino D; Siro-Brigiani G
Clin Ter; 1975 Mar; 72(5):461-91. PubMed ID: 773593
[No Abstract] [Full Text] [Related]
7. Studies in neuromuscular function. VI. Effects of anticholinesterase compounds, d-tubocurarine, and decamethonium in patients with myasthenia gravis.
GROB D; HARVEY AM; JOHNS RJ
Bull Johns Hopkins Hosp; 1956 Oct; 99(4):219-38. PubMed ID: 13364533
[No Abstract] [Full Text] [Related]
8. Myasthenia gravis: effect of the serum and serum globulin on neuromuscular transmission.
Namba T; Grob D
Neurology; 1968 Mar; 18(3):273. PubMed ID: 5689669
[No Abstract] [Full Text] [Related]
9. Myasthenia gravis in children and its anaesthetic implications.
Brown TC; Gebert R; Meretoja OA; Shield LK
Anaesth Intensive Care; 1990 Nov; 18(4):466-72. PubMed ID: 2268010
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction.
Bender AN; Ringel SP; Engel WK; Daniels MP; Vogel Z
Lancet; 1975 Mar; 1(7907):607-9. PubMed ID: 47950
[No Abstract] [Full Text] [Related]
11. Ultra-structure of the myoneural junction in myasthenia gravis.
BICKERSTAFF ER; EVANS JV; WOOLF AL
Nature; 1959 Nov; 184(Suppl 19)():1500. PubMed ID: 13800492
[No Abstract] [Full Text] [Related]
12. The role of humoral and cellular immune factors in neuromuscular block in myasthenia gravis.
Namba T; Nakata Y; Grob D
Ann N Y Acad Sci; 1976; 274():493-515. PubMed ID: 786115
[TBL] [Abstract][Full Text] [Related]
13. Influence of calcium antagonist drugs in myasthenia gravis in the elderly.
Pina Latorre MA; Cobeta JC; Rodilla F; Navarro N; Zabala S
J Clin Pharm Ther; 1998 Oct; 23(5):399-401. PubMed ID: 9875690
[TBL] [Abstract][Full Text] [Related]
14. Observations on the nature of the neuromuscular block in myasthenia gravis.
GROB D; JOHNS RJ; HARVEY AM
Trans Assoc Am Physicians; 1955; 68():50-3. PubMed ID: 13299310
[No Abstract] [Full Text] [Related]
15. Plasma concentration and pharmacological effects of pyridostigmine in patients with myasthenia gravis [proceedings].
Calvey TN; Chan K
Br J Clin Pharmacol; 1977 Jun; 4(3):404P. PubMed ID: 197984
[No Abstract] [Full Text] [Related]
16. Abnormalities in the fine structure of the neuromuscular junction in patients with myasthenia gravis.
ZACKS SI; BAUER WC; BLUMBERG JM
Nature; 1961 Apr; 190():280-1. PubMed ID: 13787615
[No Abstract] [Full Text] [Related]
17. The use of sugammadex in a patient with myasthenia gravis.
Unterbuchner C; Fink H; Blobner M
Anaesthesia; 2010 Mar; 65(3):302-5. PubMed ID: 20105151
[TBL] [Abstract][Full Text] [Related]
18. Acute effects of verapamil on neuromuscular transmission in patients with myasthenia gravis.
Lee SC; Ho ST
Proc Natl Sci Counc Repub China B; 1987 Jul; 11(3):307-12. PubMed ID: 2827211
[TBL] [Abstract][Full Text] [Related]
19. An electrophysiologic study of the neuromuscular junction in myasthenia gravis.
DAHLBACK O; ELMQVIST D; JOHNS TR; RADNER S; THESLEFF S
J Physiol; 1961 Apr; 156(2):336-43. PubMed ID: 13719322
[No Abstract] [Full Text] [Related]
20. Mivacurium chloride and myasthenia gravis.
Seigne RD; Scott RP
Br J Anaesth; 1994 Apr; 72(4):468-9. PubMed ID: 8155454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
